Jennifer L. Vande Voort, M.D., is a clinician-researcher whose work spans child, adolescent and adult psychiatry. Her research primarily surrounds mood disorders with the goal to personalize treatment and pursue novel therapeutics.
- Ketamine use for treatment-resistant depression in adults
- Impact of ketamine on suicidal ideation
- Use of pharmacogenomics testing in adolescent depression
- Childhood mental illness impacting functional outcomes and resource utilization
Significance to patient care
Depression can be a difficult-to-treat illness. As a field, novel treatment approaches are needed; Dr. Vande Voort's work strives to find the right treatment for the each patient.
In adults dealing with treatment-resistant depression, ketamine can be an effective treatment, but much more needs to be learned about this medication and its long-term side effects. The goal of Dr. Vande Voort and her colleagues is to find a personalized approach to mood disorder treatment and research novel approaches that are emerging in the field.